在局部发达的头部和部状细胞癌中,放射治疗和化疗组合
1Graduate School of Xiangya Hospital, Central South University, Hunan, China.
概括
该网络对局部发达的头支状细胞癌 (LA-HNSCC) 的分析发现,布罗利祖马布加放射治疗显示出改善生存的趋势. 毒性风险是可以管理的,与思普拉丁和免疫疗法组合不同.
科学领域:
- 在瘤学瘤学.
- 放射治疗研究 放射治疗研究
- 临床试验分析
背景情况:
- 局部发达的头部和部状细胞癌 (LA-HNSCC) 需要有效的治疗策略.
- 放射治疗是一种基石治疗,通常与全身疗法相结合.
研究的目的:
- 为了比较放射治疗与LA-HNSCC中不同治疗策略的疗效和安全性.
- 通过网络元分析 (NMA) 来合成随机对照试验 (RCT) 的证据.
主要方法:
- 进行了贝叶斯网络对14项涉及超过5900名患者的RCT的元分析.
- 评估的整体存活率 (OS),无进展存活率 (PFS) 和等级≥3毒性.
- 进行敏感性分析以确保调查结果的可靠性.
主要成果:
- 布罗利祖马布加辐射疗法显示,对改善OS和PFS的趋势并不显著.
- 布罗利祖马布和放射治疗的组合显示出可控的毒性.
- 用思普拉丁和免疫疗法进行的放射治疗显示出更高的毒性率.
结论:
- 优化放射治疗和组合疗法对于LA-HNSCC治疗至关重要.
- 识别预测生物标志物对于个性化治疗方法至关重要.
- 对新型治疗组合的进一步研究是有必要的.
相关概念视频
02:49Cancer Therapies
10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
752
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
752
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K